Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.35 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL991670 | 0.94 | ZDHHC20 (0.38) | ZDHHC20ZDHHC2TSHRALDH1A1 | |
| SCHEMBL14837310 | 0.92 | ZDHHC20 (0.40) | ZDHHC20ZDHHC2TSHRALDH1A1 | |
| SCHEMBL991864 | 0.92 | ZDHHC20 (0.40) | ZDHHC20ZDHHC2TSHRALDH1A1 | |
| SCHEMBL16776767 | 0.89 | ZDHHC20 (0.42) | ZDHHC20ZDHHC2TSHRALDH1A1 | |
| SCHEMBL14341773 | 0.89 | ZDHHC20 (0.38) | ZDHHC20ZDHHC2TSHRALDH1A1 | |
| SCHEMBL16776749 | 0.86 | ZDHHC20 (0.44) | ZDHHC20ZDHHC2TSHRALDH1A1 | |
| SCHEMBL632654 | 0.86 | — | — | |
| SCHEMBL2455781 | 0.86 | ZDHHC20 (0.44) | ZDHHC20ZDHHC2TSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL27955704 | 0.84 | MAPT (0.36) | ZDHHC20ZDHHC2TSHRALDH1A1CNR1 | |
| SCHEMBL3255350 | 0.84 | ALDH1A1 (0.38) | ZDHHC20ZDHHC2TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026572-A1 | OLEOPHOBIC FLUOROPOLYMERS AND FILTER MATERIALS PREPARED THEREFROM | MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT | 2023-01-26 | — | — | US | claimed |
| WO-2023272451-A1 | OLEOPHOBIC FLUOROPOLYMERS AND FILTER MATERIALS PREPARED THEREFROM | ENTEGRIS, INC. (US) | 2023-01-05 | — | — | WO | claimed |
| CN-108463217-A | Nano particle with active targeting | 克里斯特递送有限公司 | 2018-08-28 | — | — | CN | claimed |
| EP-3016969-A1 | IMMUNOTHERAPY | The University Of Birmingham (GB) | 2016-05-11 | — | — | EP | claimed |
| US-20160039942-A1 | IMMUNOTHERAPEUTIC MOLECULES AND USES | THE UNIVERSITY OF BIRMINGHAM (GB) | 2016-02-11 | — | — | US | claimed |
| US-20150250868-A1 | Re-Directed Immunotherapy | THE UNIVERSITY OF BIRMINGHAM (GB) | 2015-09-10 | — | — | US | claimed |
| US-20150183875-A1 | IMMUNOTHERAPEUTIC MOLECULES AND USES | UNIVERSITY OF BIRMINGHAM (GB) | 2015-07-02 | — | — | US | claimed |
| WO-2015001361-A1 | IMMUNOTHERAPY | THE UNIVERSITY OF BIRMINGHAM (GB) | 2015-01-08 | — | — | WO | claimed |
| EP-2819701-A1 | IMMUNOTHERAPEUTIC MOLECULES AND USES | The University Of Birmingham (GB) | 2015-01-07 | — | — | EP | claimed |
| WO-2014181085-A1 | TUMOUR THERAPY | BAGSHAWE KENNETH DAWSON (GB) | 2014-11-13 | — | — | WO | claimed |
| CN-1665552-A | Intraocular lens with modified surface | BAUSCH & LOMB (US) | 2005-09-07 | — | — | CN | claimed |
| CN-1658808-A | Polymeric material for use as photoablatable inlay | BAUSCH & LOMB (US) | 2005-08-24 | — | — | CN | claimed |
| US-20050181378-A1 | For PCR and DNA sequencing; electrophoresis; microfluidics | APPLERA CORPORATION (US) | 2005-08-18 | — | — | US | claimed |
| US-20020127229-A1 | Tumour therapy | BAGSHAWE KENNETH DAWSON (GB) | 2002-09-12 | — | — | US | claimed |
| JP-2001505220-A | — | — | 2001-04-17 | — | — | JP | claimed |
| EP-0918545-B1 | TUMOUR THERAPY | ENZACTA R & D LTD (GB) | 2000-07-12 | — | — | EP | claimed |
| CN-1259875-A | Pharmaceutical compositions comprising antibody-enzyme conjugates conjugated to prodrugs | SCHOOL OF PHARMACY UNIV OF LAN (GB) | 2000-07-12 | — | — | CN | claimed |
| EP-0918545-A2 | TUMOUR THERAPY | ENZACTA R & D LIMITED (GB) | 1999-06-02 | — | — | EP | claimed |
| WO-1998024478-A2 | TUMOUR THERAPY | ENZACTA R & D LIMITED (GB) | 1998-06-11 | — | — | WO | claimed |
| US-4166804-A | Polymeric color indicators and a method of their preparation | CESKOSLOVENSKA AKADEMIE VED (CS) | 1979-09-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020127229-A1 | Tumour therapy | SERPINA3, SERPINE1, SERPINB1 | ZDHHC20 1854/4885ZDHHC2 2206/4885TSHR 2541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.